Bimzelx 160 mg solution for injection in Pre-filled syringe – patient leaflet, side effects, dosage

What Bimzelx is and what it is used for

What Bimzelx is

Bimzelx contains the active substance bimekizumab.

What Bimzelx is used for

Bimzelx is used to treat the following inflammatory diseases:

Plaque psoriasis

Psoriatic arthritis

Axial spondyloarthritis, including

non-radiographic axial spondyloarthritis and ankylosing spondylitis (radiographic axial spondyloarthritis)

Hidradenitis suppurativa

Plaque psoriasis

Bimzelx is used in adults to treat a skin condition called plaque psoriasis. Bimzelx reduces the symptoms, including pain, itching, and scaling of the skin.

Psoriatic arthritis

Bimzelx is used to treat adults with psoriatic arthritis. Psoriatic arthritis is a disease that causes inflamed joints, often accompanied by plaque

PC Code: CIB73487F_MU1 MOCK-UP

01 Page: 4 of 40 = Text free area

100% unvarnished

psoriasis. If you have active psoriatic arthritis, you may first be given other medicines. If these medicines do not work well enough or in case of intolerance, you will be given Bimzelx either alone or in combination with another medicine called methotrexate.

Bimzelx reduces inflammation and can therefore help to reduce pain, stiffness, swelling in and around your joints, psoriatic skin rash, psoriatic nail damage and slow down the damage to the cartilage and bone of the joints involved in the disease. These effects can help you to control signs and symptoms of the disease, ease your normal daily activities, reduce tiredness, and improve your quality of life.

Axial spondyloarthritis, including non-radiographic axial spondyloarthritis and ankylosing spondylitis (radiographic axial spondyloarthritis)

Bimzelx is used to treat adults with an inflammatory disease primarily affecting the spine which causes inflammation of the spinal joints, called axial spondyloarthritis. If the condition is not visible using X-rays, it is referred to as “non-radiographic axial spondyloarthritis”; if it occurs in patients with visible signs on X-rays, it is referred to as “ankylosing spondylitis” or “radiographic axial spondyloarthritis”.

If you have axial spondyloarthritis you will first be given other medicines. If you do not respond well enough to these medicines, you will be given Bimzelx to reduce the signs and symptoms of the disease, reduce inflammation and improve your physical function. Bimzelx can help to reduce back pain, stiffness and tiredness, which can ease your normal daily activities and improve your quality of life.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

Hidradenitis suppurativa

Bimzelx is used in adults to treat a condition called hidradenitis suppurativa (sometimes called acne inversa or Verneuil’s disease). Hidradenitis suppurativa is a chronic inflammatory skin disease that causes painful lesions like tender nodules (lumps) and abscesses (boils), and lesions that may leak pus. It most commonly affects specific areas of the skin such as under the breasts, the armpits, inner thighs, groin and buttocks. Scarring may also occur in affected areas. You will first be given other medicines. If you do not respond well enough to these medicines, you will be given Bimzelx.

Bimzelx reduces the inflammatory nodules (lumps), abscesses (boils), and lesions that may leak pus, as well as pain caused by hidradenitis suppurativa.

How Bimzelx works

Bimekizumab, the active substance in Bimzelx, belongs to a group of medicines called interleukin (IL) inhibitors. Bimekizumab works by reducing the activity of two proteins called IL-17A and IL-17F, which are involved in causing inflammation. There are higher levels of these proteins in inflammatory diseases such as psoriasis, psoriatic arthritis, axial spondyloarthritis and hidradenitis suppurativa.

What you need to know before you use Bimzelx

Do not use Bimzelx

if you are allergic to bimekizumab or any of the other ingredients of this medicine (listed in section 6).

if you have an infection, including tuberculosis (TB), which your doctor thinks is important.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

Warnings and precautions

Talk to your doctor, pharmacist or nurse before using Bimzelx if:

you have an infection or an infection that keeps coming back.

you recently had or plan to have a vaccination. You should not be given certain types of vaccines (live vaccines) while using Bimzelx. you have ever had tuberculosis (TB). you have ever had inflammatory bowel disease (Crohn’s disease or ulcerative colitis).

Inflammatory bowel disease (Crohn’s disease or ulcerative colitis)

Stop using Bimzelx and tell your doctor or get medical help immediately if you notice blood in the stool, abdominal cramps, pain, diarrhoea or weight loss. These may be signs of new or worsening inflammatory bowel disease (Crohn’s disease or ulcerative colitis).

Look out for infections and allergic reactions

Bimzelx can rarely cause serious infections. Talk to your doctor or get medical help immediately if you notice any signs of a serious infection. Such signs are listed under “Serious side effects” in section 4.

Bimzelx can potentially cause serious allergic reactions. Talk to your doctor or get medical help immediately if you notice any signs of a serious allergic reaction. Such signs may include: difficulty breathing or swallowing

low blood pressure, which can make you dizzy or light-headed

swelling of the face, lips, tongue or throat severe itching of the skin, with a red rash or raised bumps.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

Children and adolescents

Do not give this medicine to children and young people under 18 years of age. This is because it has not yet been adequately studied in this age group.

Other medicines and Bimzelx

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Pregnancy, breast-feeding and fertility

If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine. It is preferable to avoid the use of Bimzelx in pregnancy. This is because it is not known how this medicine will affect the baby.

If you are a woman who can become pregnant, you should use contraception while using this medicine and for at least 17 weeks after your last dose of Bimzelx.

If you are breast-feeding or are planning to breast-feed, talk to your doctor before using this medicine. You and your doctor should decide if you can breast-feed or use Bimzelx.

Driving and using machines

Bimzelx is unlikely to affect your ability to drive and use machines.

Bimzelx contains polysorbate 80

This medicine contains 0.4 mg of polysorbate 80 in each 1 mL solution. Polysorbates may cause allergic reactions. Tell your doctor if you have any known allergies.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

Bimzelx contains sodium

This medicine contains less than 1 mmol (23 mg) sodium per dose, that is to say essentially “sodium free”.

How to use Bimzelx

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

How much Bimzelx is given and for how long

Plaque psoriasis

The recommended dose, given as injections under your skin (‘subcutaneous injections’) is as follows: 320 mg (given as two pre-filled syringes, containing 160 mg each) at weeks 0, 4, 8, 12, 16. From week 16, you will use 320 mg (two pre-filled syringes, containing 160 mg each) every 8 weeks. If you weigh more than 120 kg, your doctor may decide to continue your injections every 4 weeks from week 16.

Psoriatic arthritis

The recommended dose, given as an injection under your skin (‘subcutaneous injections’) is as follows: 160 mg (given as one pre-filled syringe containing 160 mg) every 4 weeks.

If you have psoriatic arthritis with coexistent moderate to severe plaque psoriasis, the recommended dose regimen is the same as for plaque psoriasis. After week 16, your doctor may adapt your injections to 160 mg every 4 weeks, depending on your joint symptoms.

Axial spondyloarthritis, including non-radiographic axial spondyloarthritis and ankylosing spondylitis (radiographic axial spondyloarthritis)

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

The recommended dose, given as an injection under your skin (‘subcutaneous injection’) is as follows: 160 mg (given as one pre-filled syringe containing 160 mg) every 4 weeks.

Hidradenitis suppurativa

The recommended dose, given as injections under your skin (‘subcutaneous injections’) is as follows: 320 mg (given as two pre-filled syringes, containing 160 mg each) every 2 weeks until week 16.

From week 16, you will use 320 mg (two pre-filled syringes, containing 160 mg each) every 4 weeks.

You and your doctor or nurse will decide if you should inject this medicine yourself. Do not inject this medicine unless you have been trained by a healthcare professional. A caregiver may also give your injections after they have been trained.

Read the ‘Instructions for use’ at the end of this leaflet before injecting Bimzelx 160 mg solution for injection in pre-filled syringe yourself.

If you use more Bimzelx than you should

Tell your doctor if you have used more Bimzelx than you should or if you have injected your dose earlier than you should.

If you forget to use Bimzelx

Talk to your doctor if you have forgotten to inject a dose of Bimzelx.

If you stop using Bimzelx

Talk to your doctor before you stop using Bimzelx. If you stop treatment, your symptoms may come back.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

Tell your doctor or get medical help immediately if you get any of the following side effects:

Possible serious infection - the signs may include: fever, flu-like symptoms, night sweats feeling tired or short of breath, cough which will not go away

warm, red and painful skin, or a painful skin rash with blisters

Your doctor will decide if you can keep using Bimzelx.

Other side effects

Tell your doctor, pharmacist or nurse if you get any of the following side effects:

Very common (may affect more than 1 in 10 people)

upper respiratory infections with symptoms such as sore throat and stuffy nose

Common (may affect up to 1 in 10 people) thrush in the mouth or throat with symptoms such as white or yellow patches; red or sore mouth and pain with swallowing

fungal infection of the skin, such as athlete’s foot between the toes

ear infections

cold sores (herpes simplex infections) stomach flu (gastroenteritis)

inflamed hair follicles which may look like pimples

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

headache

itchy, dry skin or an eczema-like rash sometimes with swollen and reddened skin (dermatitis) acne

redness, pain or swelling and bruising at the site of injection

feeling tired

fungal infection of the vulvovaginal area (vaginal thrush)

Uncommon (may affect up to 1 in 100 people) lowered levels of white blood cells (neutropenia) fungal infections of the skin and mucous membranes (including oesophageal candidiasis) discharge from the eye with itching, redness and swelling (conjunctivitis)

blood in the stool, abdominal cramps and pain, diarrhoea or weight loss (signs of bowel problems)

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:

Yellow Card Scheme

Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

How to store Bimzelx

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.

Store in a refrigerator between 2°C and 8°C. Do not freeze.

Keep the pre-filled syringes in the original carton in order to protect from light.

Bimzelx can be kept out of the refrigerator for up to 25 days. This must be in the outer carton, not above 25°C and away from direct light. Do not use the pre-filled syringes after this time period. There is a space on the box so you can write the date it was taken out of the refrigerator.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Contents of the pack and other information

What Bimzelx contains

The active substance is bimekizumab. Each pre-filled syringe contains 160 mg of bimekizumab in the 1 mL solution.

The other ingredients are glycine, sodium acetate trihydrate, glacial acetic acid, polysorbate 80 and water for injections (see section 2 “Bimzelx contains polysorbate 80” and “Bimzelx contains sodium”).

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

What Bimzelx looks like and contents of the pack

Bimzelx is a clear to slightly opalescent liquid. Its colour may vary from colourless to pale brownish-yellow. It comes in a single use disposable pre-filled syringe with needle cap.

Bimzelx 160 mg solution for injection in pre-filled syringe is available in unit packs containing 1 or 2 pre-filled syringe(s) and in multipacks comprising 3 cartons, each containing 1 pre-filled syringe, or in multipacks comprising 2 cartons, each containing 2 pre-filled syringes.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

UCB Pharma Limited

208 Bath Road

Slough

Berkshire

SL1 3WE, United Kingdom.

Manufacturer

UCB Pharma S.A.

Chemin du Foriest

B-1420 Braine-l’Alleud, Belgium

This leaflet was last revised in 03/2026

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

Instructions for use

Read all the instructions below before you use Bimzelx 160 mg solution for injection in pre-filled syringe.

Bimzelx 160 mg pre-filled syringe at a glance (see Figure A):

Needle

Needle Cap Syringe Barrel

Finger

Grip

Plunger Rod

Plunger Head

Important information:

Your healthcare professional should show you how to prepare and inject Bimzelx using the 160 mg pre-filled syringe. Do not inject yourself or someone else until you have been shown how to inject Bimzelx the right way.

You and/or your caregiver should read these Instructions for Use before each use of Bimzelx. Call your healthcare professional if you or your caregiver have any questions about how to inject Bimzelx the right way.

Depending on your prescribed dose you will need to use 1 or 2 Bimzelx 160 mg pre-filled syringe(s). One pre-filled syringe is needed for a 160 mg dose and 2 pre-filled syringes (one after the other) are needed for a 320 mg dose. Each pre-filled syringe is for one-time (single-dose) use only.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

The 160 mg pre-filled syringe has a needle safety feature. This will cover the needle automatically after the injection is finished. The needle safety feature will help to prevent needle injury to anyone who handles the pre-filled syringe after injection.

Do not use this medicine and return it to the pharmacy if:

the expiry date (EXP) has passed.

the carton seal is broken.

the pre-filled syringe has been dropped or looks damaged.

the liquid has ever been frozen (even if thawed).

For a more comfortable injection: Take the 160 mg pre-filled syringe(s) out of the refrigerator and let it / them sit on a flat surface at room temperature for 30 to 45 minutes before injecting.

Do not warm in any other way, such as in a microwave or in hot water.

Do not shake the pre-filled syringe(s). Do not uncap the pre-filled syringe(s) until you are ready to inject.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

Follow the steps below each time you use Bimzelx.

1Step

Setting up for your injection(s)

Depending on your prescribed dose, place the following items on a clean flat, well-lit work surface, like a table:

1 or 2 Bimzelx 160 mg pre-filled syringe(s)

You will also need (not included in the carton): 1 or 2 alcohol wipe(s)

1 or 2 clean cotton ball(s)

1 sharps disposal container. See “Throw away the used Bimzelx pre-filled syringe” at the end of these Instructions for Use.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

2Step Choose injection site and prepare your injection

2a: Choose your injection site

The places you may choose for your injection are:

B

o your stomach (abdomen) or your thigh (see Figure B).

Abdomen

or thigh

C

o the back of your arm (see Figure C). Bimzelx may be injected into the back of your arm by a healthcare professional or caregiver only.

Back of arm

Do not inject into areas where the skin is tender, bruised, red, scaly, hard or areas with scars or stretch marks.

Do not inject within 5 cm of the belly-button (navel).

If a second injection is needed for your prescribed dose (320 mg), you should use a different place for your second injection. Do not use the same place to inject twice in a row.

2b: Wash your hands well with soap and water and dry with a clean towel

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

2c: Prepare your skin

Clean the injection site with an alcohol wipe. Let the area dry completely. Do not touch the cleaned area again before injecting.

2d: Check the pre-filled syringe (see Figure D)

Make sure the name Bimzelx and expiry date appear on the label.

Check the medicine through the viewing window. The medicine should be clear to slightly opalescent and free of particles. Its colour may vary from colourless to pale brownish-yellow. You may see air bubbles in the liquid. This is normal.

Do not use the Bimzelx pre-filled syringe if the medicine is cloudy, discoloured, or has particles.

Expiry Date

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

3Step

Inject Bimzelx

3a: Remove the pre-filled syringe needle cap

Hold the pre-filled syringe around the finger grip with one hand. Pull the cap straight off the pre-filled syringe with the other hand (see Figure E). You may see a drop of liquid on the tip of the needle, this is normal.

o Do not touch the needle or let the needle touch any surface.

o Do not hold the plunger rod when you remove the cap. If you accidentally remove the plunger rod, throw the pre-filled syringe in the sharps disposal container and get a new one.

o Do not put the needle cap back on. If you do, you could damage the needle or prick yourself by accident.

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

3b: Gently pinch and hold with one hand a fold of skin that you cleaned for the injection. With the other hand, insert the needle into your skin at about a 45 degree angle

45°

Push the needle all the way in. Then gently let go of your skin. Make sure the needle is in place (see Figure F).

3c: Firmly push the plunger head all the way down until all the medicine is injected (see Figure G)

All the medicine is injected when you cannot push the plunger head any further (see Figure H).

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

3d: Lift your thumb off the plunger head (see Figure I). The needle will automatically move back in and lock in place

Press a dry cotton ball over the injection site for a few seconds. Do not rub the injection site. You may see slight bleeding or a drop of liquid. This is normal. You may cover the injection site with a small adhesive plaster, if needed.

4Step Throw away the used Bimzelx pre-filled syringe

Put the used

pre-filled syringe in a sharps disposal container straight away after use (see Figure J).

If you need to have a second injection as prescribed by your doctor, use a new Bimzelx 160 mg pre-filled syringe and repeat steps 2 to 4.

Make sure to select a new injection site for your second injection.

PC Code: CIB73487F_MU1 MOCK-UP

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

100% unvarnished

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area 100% unvarnished

COVER PAGE 3

PC Code: CIB73487F_MU1 MOCK-UP

01

= Text free area

= No print area

COVER PAGE 4

(back)

COVER PAGE 1

(front)

PC Code: CIB73487F_MU1 MOCK-UP

01